Explore the full directors' dealings record of Allergy Therapeutics Plc, a listed equity based in United Kingdom. Shares trade on UK GB, under the supervision of RNS (LSE). The latest transaction was filed on 15 January 2025 (Purchase). Among the most active insiders: ZQ Capital Management Limited. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations